Aquestive Therapeutics (AQST) Leases (2019 - 2025)
Historic Leases for Aquestive Therapeutics (AQST) over the last 7 years, with Q3 2025 value amounting to $4.8 million.
- Aquestive Therapeutics' Leases fell 1018.83% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 1018.83%. This contributed to the annual value of $5.2 million for FY2024, which is 674.82% down from last year.
- Per Aquestive Therapeutics' latest filing, its Leases stood at $4.8 million for Q3 2025, which was down 1018.83% from $4.9 million recorded in Q2 2025.
- Over the past 5 years, Aquestive Therapeutics' Leases peaked at $5.9 million during Q1 2023, and registered a low of $2.1 million during Q3 2022.
- In the last 5 years, Aquestive Therapeutics' Leases had a median value of $5.0 million in 2025 and averaged $4.4 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 2821.39% in 2022, then surged by 17072.59% in 2023.
- Over the past 5 years, Aquestive Therapeutics' Leases (Quarter) stood at $2.7 million in 2021, then surged by 91.23% to $5.2 million in 2022, then increased by 6.64% to $5.6 million in 2023, then dropped by 6.75% to $5.2 million in 2024, then fell by 7.97% to $4.8 million in 2025.
- Its Leases was $4.8 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.0 million in Q1 2025.